How is Globyz Biopharma Services Innovating through the Pandemic and Beyond to Define the Future of Healthcare?



Globyz, one of That's Nice's Road to 2021 sponsors, discusses how the company is innovating to face the challenges of the COVID-19 pandemic and beyond to face the future of healthcare.

Maintaining an innovative culture and investing in innovation is key to Globyz’s overall strategy. Although the company has robust technologies in place, Globyz continually scans for new technologies to help improve the quality of service, expedited deliveries, and overall customer experience. As an example, Globyz is currently offering thermal packaging depot services for passive parcel and pallet shipper rentals, preconditioning, reverse logistics, and refurbishment. Globyz is also working on a biodegradable thermal packaging solution for 2–8 °C and 15–25 °C shipments that will replace the need for expanded polystyrene (EPS) thermal shippers. To remain competitive, the company partners with progressive external service providers to enhance their capabilities. To complement the solutions mentioned above, Globyz is also finalizing a customized IoT real-time GPS tracking device for end-toend security, visibility, and data analytics of its assets and temperature-controlled shipments.

Other innovation areas that the company is watching and expects to have a significant impact on the industry include personalized and targeted therapies, the increase of virtual/remote and hybrid trials, direct-to-patient (DTP) services, the application of digital technologies, and the development of more treatments for rare diseases.

Globyz’s goal is to become a leading onestop- shop for global comparator sourcing, the procurement of clinical trial materials and ancillary supplies, GMP storage, packaging, labeling and kitting, and GDP distribution for pharma and biotechnology sponsors, as well as CROs, CMOs, CDMOs and medical device companies throughout the Americas, Europe, and Asia. Globyz has an international presence, with GMP depots strategically located in the United States, Canada, Germany, India, Singapore, and Brazil, and is expanding its global footprint to meet the growing demand for clinical supply services. Notably, the company recently hired three business development managers in Philadelphia, Munich, and Mumbai to reinforce their presence in those growing markets, with additional hirings planned for the U.S. and Canadian markets for various functions. Globyz is also adding a new and larger facility in Toronto with GMP depot capabilities. The new logistics hub is conveniently located near the Toronto Pearson International Airport (YYZ) and features dedicated space for clinical and commercial pharmaceutical drug storage, controlled substances, packaging and labeling, pick and pack, inventory management, returns, reconciliations, and destruction. Globyz’s new cGMP Toronto depot triples its current size, will comply with Health Canada’s GMP guidelines, and will be equipped with cutting-edge technology to monitor and handle the full spectrum of temperature- controlled materials, packaging, and shipments. As a one-source solution for comparator drugs, packaging and labeling, GMP storage, and temperature-controlled logistics, Globyz consolidates broad services for clients.

As a one-source solution for comparator drugs, packaging and labeling, GMP storage, and temperature-controlled logistics, Globyz consolidates broad services for clients.

There is no debating that the COVID-19 pandemic has significantly impacted clinical trial logistics. Study recruitment and screening have been impacted; the industry is dealing with many API shortages, working around regional lockdowns, and finding innovative ways to remain productive despite import/export restrictions. The pandemic has also prompted the cancellation of conferences and suspended in-person meetings. However, the situation has led to an increase in investment and activities in COVID-related studies. It has also made it clear that relying on one country for all products and service requirements is risky and short-sighted. Even though COVID-19 has presented a plethora of challenges, Globyz has been able to streamline processes, enhance reliability, and reduce costs while remaining flexible and compliant.

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Globyz Biopharma Services

Globyz Biopharma Services is dedicated to sourcing and supplying commercial medicines for analytical research, drug development, clinical trials or bioequivalence studies across all therapeutic areas. Globyz Biopharma Services include comprehensive solutions for global comparator sourcing and storing and distributing pharmaceuticals, materials, and ancillary supplies for clinical trials, as well as GMP storage, packaging, labeling, kitting, controlled drug services, importer of record and QP services, and global GxP temperature- controlled logistics.